Articles
Optimizing Cardiovascular Outcomes in Patients with Type 2 Diabetes—Clinical Implications of the FIELD Results
Citation:
US Cardiology 2006;3(2):47–53
Overview to Antihypertensive and Lipid-lowering Therapies and Patient Care
Citation:
US Cardiology 2006;3(2):18–9
Reducing the Threat of Vascular Disease in Patients with Hypertension and Hyperlipidemia by Addressing Poor Adherence
Citation:
US Cardiology 2006;3(2):22–3
Support for Combined Administration of Antihypertensive and Lipid-lowering Agents to Reduce Cardiovascular Events - The Emergence of the Multipill
Citation:
US Cardiology 2006;3(2):1–3
The Role of Angiotensin Receptor Blockers in Cardiovascular Protection Beyond Blood Pressure Control
Citation:
US Cardiology 2006;3(2):37–9
The Role of Angiotensin Receptor Blockers in Treating Hypertension
Citation:
US Cardiology 2006;3(2):28–31
The Role of Myocardial Perfusion Imaging in the Clinical Evaluation of CAD
Citation:
US Cardiology 2006;3(2):68–72
Treating the Common Dyslipidemia in Patients with Type 2 Diabetes—Insights from FIELD on the Effects of Fenofibrate on CVD Risk
Citation:
US Cardiology 2006;3(1):21–6
Transcatheter Interventional Techniques in Pediatric Cardiology
Citation:
US Cardiology 2005;2(1):157-8